Molecular Partners’ Post

We’re beyond excited to welcome the venerable Roslyn Schneider MD, FACP, FCCP, GFMD to ProofPilot's Strategic Advisory Board! 🎉 With 30+ years as a physician, biopharma exec, and patient advocate, Roslyn has been behind several blockbuster therapies and is all about putting patients first. 🩺 Her deep expertise will be key in shaping our strategy as we continue to put patients at the heart of clinical trials. 💡Roslyn's words say it all: “Joining ProofPilot feels like a natural extension of my passion for putting patients first.” Want to see the full story? Read the press release - link in comments 👇🏼 #PatientEngagement #ClinicalTrials #ClinicalResearch #HealthInnovation

𝗡𝗲𝘅𝘁-𝗴𝗲𝗻 𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗮𝗰𝗰𝗲𝘀𝘀 𝗶𝘀 𝗼𝗻 𝘁𝗵𝗲 𝗵𝗼𝗿𝗶𝘇𝗼𝗻!🌅 Venova Medical, Inc. Medical secured a US$30 million Series B funding round, co-led by CHV (Catalyst Health Ventures) and a leading medical device company, alongside notable investors like ShangBay Capital, Mirae Asset Capital, KOFA Healthcare, Cadence Healthcare Ventures, and Aphelion Capital. This is a significant milestone that will undoubtedly propel the development of their groundbreaking Velocity pAVF System. The Velocity pAVF System represents a transformative leap in hemodialysis access, offering a minimally invasive solution for creating arteriovenous fistulas (AVFs). This innovative technology is designed to provide optimal and durable fistula flow, ensuring safer, more effective, and longer-lasting vascular access for patients undergoing dialysis. In the words of CEO Erik van der Burg, "We believe that the Velocity pAVF System will become the new standard of care, reducing barriers and improving outcomes for patients starting dialysis." The addition of Darshana Zaveri to Venova’s board of directors is another exciting development. Her expertise will be invaluable as Venova Medical continues its journey towards FDA approval and market expansion. This milestone marks a critical step forward in improving the quality of life for patients with kidney failure. Here's to the continued success of Venova Medical in revolutionizing vascular access for hemodialysis! #MedicalDevices #Hemodialysis #VascularAccess #VenovaMedical #SeriesB #PatientCare

Dear MedVector Friends and Stakeholders, Great news, the industry seems to be at a tipping point, and we wanted to open the doors to smaller investors before the VC frenzy begins. ($500 minimum) Since our last StartEngine round, we've made a lot of progress in the buildout of MedVector. Specifically, we've: • Raised $1.5M from larger investors, for a total of $3.5 million total invested. • Signed NDAs with 9 of the top 15 pharmaceutical companies, with several proposals out. • Are the official partner of the State of Delaware for clinical research. During our last round, our valuation was $10M; today, the cap is $25M, so our early investors are doing great! If you'd like to participate, learn more, or simply watch our momentum grow, check out our campaign page below! (Note: Existing investors and early investors get bonuses.) All the best, Scott Stout MedVector CEO https://lnkd.in/edhdwiPk

75 Years of medical innovation…👍

📢 Johnson & Johnson has acquired Shockwave Medical, a strategic move to enhance cardiovascular care through innovative technologies. This acquisition underscores J&J's dedication to advancing medical solutions and improving patient outcomes. Check out Tuck Advisor’s M&A Matrix for an in-depth analysis of this acquisition and its impact on the future of healthcare.   #Healthcare #MedicalInnovation #JohnsonAndJohnson #ShockwaveMedical #AcquisitionNews #TuckAdvisors #MnAMatrix

Come learn more about what KPH has to offer! 💙🧡💙🧡

Reason 5 Why You Should Attend #woncaeurope2024: It's engaging discussions on clinical advancements! Check out the topics on the website: https://bit.ly/3PXC5Ry #GP #familymedicine #woncaeurope2024

Developing a new drug takes long-term commitment but the reward can be life-changing. Watch this video as Race Oncology CEO speaks with HotCopper to break down the drug development process and biotech companies' appeal to the investors. #oncologydrugs #biotech #investment

Market capitalization of Apollo Medical Holdings (AMEH) Market cap: $1.83 Billion As of June 2024 Apollo Medical Holdings has a market cap of $1.83 Billion. This makes Apollo Medical Holdings the world's 4257th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth. https://lnkd.in/e-EHk-sE

Did you miss the 5th Clinical Trial Agreements Summit? Watch On-Demand: https://ow.ly/nEL950TaYMm Stay tuned for details about the 6th Clinical Trial Agreements Summit in 2025! #DGEvents #CTASummit #ClinicalTrialAgreements